Filing Flows › Teradyne (TER) › Q3 2026
Teradyne (TER) Q3 2026 earnings results (third quarter 2026)
10-Q filed Oct 30, 2026
Teradyne (TER) reported revenue of $1.3B for the third quarter 2026 (Q3 2026), +70% from a year earlier and -2% from the quarter before. Operating margin was 30.8%, net earnings $342M (26.2% of revenue).
Teradyne, Q3 2026: revenue $1.3B (+70% year over year), operating margin 30.8%, net earnings $342M, operating cash flow $314M. The chart follows the revenue to costs, profit and cash.
| Q3 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $1.3B | -2% | +70% |
| Gross profit | $771M | -3% | +72% |
| Operating profit | $402M | -8% | +177% |
| Net earnings | $342M | -9% | +186% |
| Operating cash flow | $314M | -33% | +539% |
| Free cash flow | $227M | -40% | 96× |
What changed
Revenue was $1.3B in Q3 2026, up 70% year over year and down 2% from the previous quarter. Product was the largest line at 89% of revenue. Product added $0.53B year over year (up 84%), 99% of the total change.
Gross margin was 59.1%, up 0.6 points from Q3 2025. Operating profit was $0.40B, a 30.8% margin (up 11.9 points year over year). Of the extra revenue versus Q3 2025, 48% reached operating profit, above the 19% margin then. Operating expenses grew 21% against revenue growth of 70%. The fastest-growing cost line was Research & development (+31%). Net earnings were $0.34B, up 186% year over year. The effective tax rate was 14.7%.
Operating cash flow was $0.31B (up 539% year over year), 90% of net earnings. Non-cash charges added back $0.04B of depreciation and amortization and $0.02B of share-based compensation. Working capital and other items used $0.09B. Capital expenditures of $0.09B left free cash flow of $0.23B.
Questions
What was Teradyne's revenue in the third quarter 2026?
Teradyne (TER) reported revenue of $1.3B for the third quarter 2026 (Q3 2026), +70% from a year earlier and -2% from the quarter before.
Was Teradyne profitable in the third quarter 2026?
Operating profit was $402M (30.8% of revenue) and net earnings $342M.
Source: Teradyne 10-Q on SEC EDGAR.